Clinical Trial Update: MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT [Phase 1, Phase 2]

View source ↗

Summary

A development-stage clinical trial evaluating 68Ga-NeoBOMB1 in advanced, TKI-treated gastrointestinal stromal tumors using PET/CT has completed Phase 1 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• 68Ga-NeoBOMB1 (68Ga-NeoBOMB1)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Gastrointestinal Stromal Tumors | Phase 1, Phase 2 | Status: COMPLETED